SG11201809413RA - Detection of chromosome interaction relevant to breast cancer - Google Patents
Detection of chromosome interaction relevant to breast cancerInfo
- Publication number
- SG11201809413RA SG11201809413RA SG11201809413RA SG11201809413RA SG11201809413RA SG 11201809413R A SG11201809413R A SG 11201809413RA SG 11201809413R A SG11201809413R A SG 11201809413RA SG 11201809413R A SG11201809413R A SG 11201809413RA SG 11201809413R A SG11201809413R A SG 11201809413RA
- Authority
- SG
- Singapore
- Prior art keywords
- oxford
- international
- beaumont
- street
- oxfordshire
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/50—Other enzymatic activities
- C12Q2521/501—Ligase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/101—Crosslinking agents, e.g. psoralen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/501—Detection characterised by immobilisation to a surface being an array of oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1608000.4A GB201608000D0 (en) | 2016-05-06 | 2016-05-06 | Chromosome detection |
| PCT/GB2017/051273 WO2017191477A1 (en) | 2016-05-06 | 2017-05-08 | Detection of chromosome interaction relevant to breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809413RA true SG11201809413RA (en) | 2018-11-29 |
Family
ID=56297311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809413RA SG11201809413RA (en) | 2016-05-06 | 2017-05-08 | Detection of chromosome interaction relevant to breast cancer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11746378B2 (ja) |
| EP (1) | EP3452612B1 (ja) |
| JP (1) | JP7005596B2 (ja) |
| KR (1) | KR102453393B1 (ja) |
| CN (1) | CN109661477B (ja) |
| AU (1) | AU2017261442B2 (ja) |
| CA (1) | CA3023156A1 (ja) |
| GB (1) | GB201608000D0 (ja) |
| MY (1) | MY195357A (ja) |
| PL (1) | PL3452612T3 (ja) |
| SG (1) | SG11201809413RA (ja) |
| WO (1) | WO2017191477A1 (ja) |
| ZA (1) | ZA201806917B (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3510152A4 (en) | 2016-09-07 | 2020-04-29 | Flagship Pioneering, Inc. | METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION |
| EP4357463A2 (en) | 2016-12-01 | 2024-04-24 | Oxford BioDynamics PLC | Application of epigenetic chromsomal interactions in cancer diagnostics |
| DK3565891T3 (da) | 2017-01-09 | 2023-07-24 | Whitehead Inst Biomedical Res | Fremgangsmåder til ændring af genekspression ved forstyrrelse af transkriptionsfaktor-multimere, der strukturerer regulatoriske sløjfer |
| WO2020198704A1 (en) * | 2019-03-28 | 2020-10-01 | Phase Genomics, Inc. | Systems and methods for karyotyping by sequencing |
| EP4041894A1 (en) | 2019-09-23 | 2022-08-17 | Omega Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4a) GENE EXPRESSION |
| CN111334508B (zh) * | 2020-03-11 | 2022-04-15 | 潍坊医学院 | 一种抑制乳腺癌细胞的增殖侵袭转移的基因、表达载体 |
| CN111798919B (zh) * | 2020-06-24 | 2022-11-25 | 上海交通大学 | 一种肿瘤新抗原预测方法、预测装置及存储介质 |
| CN113436741B (zh) * | 2021-07-16 | 2023-02-28 | 四川大学华西医院 | 基于组织特异增强子区域dna甲基化的肺癌复发预测方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0417740D0 (en) * | 2004-08-10 | 2004-09-08 | Uc3 | Methods and kit for the prognosis of breast cancer |
| ES2556113T3 (es) * | 2005-07-04 | 2016-01-13 | Erasmus University Medical Center | Ensayo de captura en chip (4C) de conformación cromosómica |
| US20090299640A1 (en) | 2005-11-23 | 2009-12-03 | University Of Utah Research Foundation | Methods and Compositions Involving Intrinsic Genes |
| GB0603251D0 (en) | 2006-02-17 | 2006-03-29 | Isis Innovation | DNA conformation |
| GB0810051D0 (en) * | 2008-06-02 | 2008-07-09 | Oxford Biodynamics Ltd | Method of diagnosis |
| ES2916339T3 (es) | 2010-07-09 | 2022-06-30 | Cergentis B V | Estrategias de secuenciación de región genómica de interés 3D |
| WO2012159025A2 (en) | 2011-05-18 | 2012-11-22 | Life Technologies Corporation | Chromosome conformation analysis |
| EP2780469A1 (en) | 2011-11-18 | 2014-09-24 | Vanderbilt University | Markers of triple-negative breast cancer and uses thereof |
| JP6164689B2 (ja) * | 2013-08-30 | 2017-07-19 | 国立大学法人大阪大学 | 乳癌術前化学療法に対する感受性の診断補助方法および判定装置 |
| GB201320351D0 (en) * | 2013-11-18 | 2014-01-01 | Erasmus Universiteit Medisch Ct | Method |
| AU2015230677A1 (en) | 2014-03-11 | 2016-10-27 | The Council Of The Queensland Institute Of Medical Research | Determining cancer agressiveness, prognosis and responsiveness to treatment |
| EP3314018A1 (en) | 2015-06-24 | 2018-05-02 | Oxford Biodynamics Limited | Detection processes using sites of chromosome interaction |
-
2016
- 2016-05-06 GB GBGB1608000.4A patent/GB201608000D0/en not_active Ceased
-
2017
- 2017-05-08 CN CN201780034192.XA patent/CN109661477B/zh active Active
- 2017-05-08 US US16/098,667 patent/US11746378B2/en active Active
- 2017-05-08 JP JP2019510481A patent/JP7005596B2/ja active Active
- 2017-05-08 EP EP17723494.5A patent/EP3452612B1/en active Active
- 2017-05-08 SG SG11201809413RA patent/SG11201809413RA/en unknown
- 2017-05-08 PL PL17723494.5T patent/PL3452612T3/pl unknown
- 2017-05-08 WO PCT/GB2017/051273 patent/WO2017191477A1/en unknown
- 2017-05-08 CA CA3023156A patent/CA3023156A1/en active Pending
- 2017-05-08 AU AU2017261442A patent/AU2017261442B2/en active Active
- 2017-05-08 KR KR1020187032201A patent/KR102453393B1/ko active IP Right Grant
- 2017-05-08 MY MYPI2018703959A patent/MY195357A/en unknown
-
2018
- 2018-10-17 ZA ZA2018/06917A patent/ZA201806917B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201806917B (en) | 2022-06-29 |
| EP3452612A1 (en) | 2019-03-13 |
| CN109661477A (zh) | 2019-04-19 |
| JP2019521701A (ja) | 2019-08-08 |
| EP3452612B1 (en) | 2023-08-23 |
| KR20190025814A (ko) | 2019-03-12 |
| EP3452612C0 (en) | 2023-08-23 |
| PL3452612T3 (pl) | 2023-12-11 |
| WO2017191477A1 (en) | 2017-11-09 |
| CN109661477B (zh) | 2022-12-02 |
| US11746378B2 (en) | 2023-09-05 |
| JP7005596B2 (ja) | 2022-03-03 |
| KR102453393B1 (ko) | 2022-10-11 |
| MY195357A (en) | 2023-01-16 |
| GB201608000D0 (en) | 2016-06-22 |
| AU2017261442A1 (en) | 2018-11-22 |
| US20190241964A1 (en) | 2019-08-08 |
| CA3023156A1 (en) | 2017-11-09 |
| AU2017261442B2 (en) | 2020-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809413RA (en) | Detection of chromosome interaction relevant to breast cancer | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201805137XA (en) | Virus encoding an anti-tcr-complex antibody or fragment | |
| SG11201900772YA (en) | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors | |
| SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201910027YA (en) | Bispecific antibody against ox40 and ctla-4 | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201808708RA (en) | Heterocyclic amides useful as protein modulators | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201808476SA (en) | Recycling of polymer matrix composite | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
| SG11201811659PA (en) | Systems and methods for determining an estimated time of arrival | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201806284TA (en) | Low pressure separator having an internal divider and uses therefor | |
| SG11201809805WA (en) | Three-dimensional bioreactor for cell expansion and related applications | |
| SG11201803998PA (en) | Systems and methods for updating sequence of services | |
| SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
| SG11201901172QA (en) | A method for manufacturing a fuel component | |
| SG11201811335UA (en) | Quinolinyldiamido transition metal complexes, production and use thereof | |
| SG11201903602RA (en) | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody | |
| SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel | |
| SG11201806330UA (en) | Positive type photosensitive siloxane composition |